We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Gel Patch Improves Wound Healing and Scarring

By HospiMedica International staff writers
Posted on 02 Oct 2017
A novel prototype patch enriched with angiopoietin-like 4 (ANGPTL4) reduces inflammation in the early phase of wound healing, and helps reduce scarring during the final phase.

Developed at Nanyang Technological University (NTU; Singapore), the new patch is designed to reduce scar collagen by inhibiting a protein called Scleraxis, which is involved in collagen production via the TGFbeta-Smad3 pathway. More...
Scleraxis also plays an important role in the formation of tendons, which are composed of parallel arrays of collagen closely packed together and are thus similar in structure to scar tissue. When the TGFbeta-Smad3 pathway is turned off, collagen production stops and there is no scarring as a result.

In studies involving mice with diabetic wounds, the wound was shown to heal stronger and thrice as fast with the application of ANGPTL4. When using human fibroblasts as a preclinical model, the researchers found that ANGPTL4 binds to cadherin-11, releasing membrane-bound β-catenin, which translocates to the nucleus and upregulates the expression of an inhibitor of DNA-binding and differentiation (ID3), which also interacts with scleraxis. According to the researchers, the active ingredient ANGPTL4 can be harvested from discarded fatty tissues from patients in hospitals. The study was published on July 24, 2017, in Nature Scientific Reports.

“To reduce scars, all we had to do was to find a ‘tuning knob’ that controls the amount of collagen produced, instead of turning it off completely which is what typical anti-scarring medicine does, and which could interfere with the healing process,” said corresponding author Andrew Tan Nguan Soon, PhD, of the NTU School of Biological Sciences.

“The easy extraction of ANGPTL4 also could mean that in future, a surgeon can use the patient’s fat and turn it into a healing agent on the spot, to promote faster recovery of the patient’s wounds after an operation,” said study co-author Cleo Choong, PhD, of the NTU School of Materials Science and Engineering. “In addition, we have developed ways to package ANGPTL4 into easy-to-use formulations such as gel patches, topical creams, and injectable microcapsules.”

Collagen is the main structural protein of connective tissue, and is the most abundant protein in mammals, making up 25-35% of the whole-body protein content. It is one of the body’s key natural resources and a component of skin tissue that can benefit all stages of the wound healing process.

Related Links:
Nanyang Technological University


Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Radiation Safety Barrier
RayShield Intensi-Barrier
Floor‑Mounted Digital X‑Ray System
MasteRad MX30+
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Critical Care

view channel
Image: The 3D-printed microneedle patch boosts live-virus vaccine delivery (Photo courtesy of IIS/University of Tokyo)

3D-Printed Delivery System Enhances Vaccine Delivery Via Microneedle Array Patch

The COVID-19 pandemic underscored the need for efficient, durable, and widely accessible vaccines. Conventional vaccination requires trained personnel and cold-chain logistics, which can slow mass immunization... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.